Advertisement

MedImmune taps federal institute for research partnership

MedImmune taps federal institute for research partnership

MedImmune has tapped the National Institute of Standards and Technology to help it develop and produce biopharmaceuticals, the latest in a string of partnerships the Gaithersburg drug research firm has announced with the federal government.

The company signed a five-year agreement with the institute, giving it access to NIST's expertise in measurement. As part of the deal, MedImmune is paying for seven postdoctoral researchers at the institute who will help create measurement tools to be used in pharmaceutical research.

Advertisement

The two organizations' labs are less than a mile apart in Montgomery County. Work will take place at both sites.

MedImmune has announced a string of partnerships with federal labs in recent weeks, including its participation in a National Institutes of Health program that seeks to commercialize university research and a three-year deal to work with the National Cancer Institute on oncology drug development.

The company is the biopharmaceutical branch of British drugmaker AstraZeneca.

twitter.com/ssdance

Advertisement
Advertisement